BioAmber clinches Lanxess funding, partners with NatureWorks to form AmberWorks

BioAmber closed a Series C funding round for $30 million, with Lanxess participating in the latter of two tranches with $10 million and joining the BioAmber board. Existing investors Naxos Capital, Sofinnova Partners, Mitsui, and the Cliffton Group contributed a total of $20 million in November 2011...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Origin Materials

Company Profile | April 08, 2022

Produces CMF and hydrothermal carbon (HTC) from wood chips; develops routes for CMF derivatives like TPA for polyethylene terephthalate (PET) and FDCA for polyethylene furanoate (PEF) Primarily targets CMF as an intermediate for biobased PET production as well as specialty chemicals and ... Not part of subscription

Round two: Avantium begins construction of its FDCA flagship plant after its long-awaited financial close

News Commentary | April 21, 2022

After years of uncertainties and a huge falling out with Synvina and BASF, Avantium has finally secured the funding it needs to build its FDCA (furandicarboxylic acid) flagship plant. The company has received EUR 90 million in debt financing from a consortium of Dutch banks for the financial close. ... Not part of subscription


Company Profile | April 26, 2022

Develops a metal catalyst platform for producing chemicals like β‑propiolactone (BPL) by combining ethylene oxide (EO) with carbon monoxide (CO) Since 2019, has pivoted from targeting acrylic acid as an end‑product to targeting poly(3‑hydroxypropionate) (P3HP), a type of PHA Claims its ... Not part of subscription